Screener
Aquestive Therapeutics, Inc. AQST Business Segments — Operating Income (Loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total General and Administrative Expenses | 11,889 | 9,185 | 20,945 | 25,301 |
| Total Selling, General and Administrative Expenses | 14,063 | 12,705 | 25,040 | 31,777 |
| Total costs and expenses | 22,042 | 21,371 | 40,692 | 49,456 |
| Loss from operations | (8,223) | (11,368) | (12,427) | (30,733) |
| Other income/(expenses), net | (14,641) | (2,180) | (18,494) | (5,745) |
| Net loss before income taxes | (22,864) | (13,548) | (30,921) | (36,478) |
| Net loss | $(22,864) | $(13,548) | $(30,921) | $(36,478) |
| Comprehensive loss | $(22,864) | $(13,548) | $(30,921) | $(36,478) |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s business segments — operating income (loss)?
- Aquestive Therapeutics, Inc. (AQST) reported business segments — operating income (loss) of -$8.22M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s business segments — operating income (loss) changed year-over-year?
- Aquestive Therapeutics, Inc.'s business segments — operating income (loss) increased by 27.7% year-over-year, from -$11.37M to -$8.22M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s business segments — operating income (loss)?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s business segments — operating income (loss) has grown at a 116.9% compound annual growth rate (CAGR), from -$15.1M to -$71.05M.
- What does business segments — operating income (loss) mean?
- Measures the profit or loss generated by the segment from its core business activities, calculated as revenues minus total operating costs and expenses. This is the primary metric for assessing the operational performance and financial viability of the segment independent of financing or tax structures. A positive value indicates a self-sustaining business unit, while a negative value highlights the need for operational improvement or external funding.
Ask your AI about Aquestive Therapeutics, Inc.'s business segments — operating income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude